"{\n\t\"owner_org\": \"ff9ae098-eccc-41d8-bfcd-5e8ed047db05\",\n\t\"maintainer\":
  \"Gary Ripper\",\n\t\"relationships_as_object\": [],\n\t\"private\": false,\n\t\"maintainer_email\":
  \"gary.ripper@va.gov\",\n\t\"num_tags\": 11,\n\t\"id\": \"9858734a-428a-4fa3-b1a9-32f1896df237\",\n\t\"metadata_created\":
  \"2015-02-26T17:06:52.797142\",\n\t\"metadata_modified\": \"2015-10-08T21:50:21.891050\",\n\t\"author\":
  null,\n\t\"author_email\": null,\n\t\"state\": \"active\",\n\t\"version\": null,\n\t\"license_id\":
  \"cc-zero\",\n\t\"type\": \"dataset\",\n\t\"resources\": [],\n\t\"num_resources\":
  0,\n\t\"tags\": [{\n\t\t\"vocabulary_id\": null,\n\t\t\"display_name\": \"clozapine\",\n\t\t\"name\":
  \"clozapine\",\n\t\t\"revision_timestamp\": \"2015-02-26T17:06:52.797142\",\n\t\t\"state\":
  \"active\",\n\t\t\"id\": \"6ed3c636-b14b-40fe-a84b-4600b741d4d8\"\n\t},\n\t{\n\t\t\"vocabulary_id\":
  null,\n\t\t\"display_name\": \"clozaril\",\n\t\t\"name\": \"clozaril\",\n\t\t\"revision_timestamp\":
  \"2015-02-26T17:06:52.797142\",\n\t\t\"state\": \"active\",\n\t\t\"id\": \"442d781a-6bff-40e3-80f1-c7accce83c09\"\n\t},\n\t{\n\t\t\"vocabulary_id\":
  null,\n\t\t\"display_name\": \"drug\",\n\t\t\"name\": \"drug\",\n\t\t\"revision_timestamp\":
  \"2015-02-26T17:06:52.797142\",\n\t\t\"state\": \"active\",\n\t\t\"id\": \"0300254c-a948-4bc9-9e40-0de6992857f6\"\n\t},\n\t{\n\t\t\"vocabulary_id\":
  null,\n\t\t\"display_name\": \"fda\",\n\t\t\"name\": \"fda\",\n\t\t\"revision_timestamp\":
  \"2015-02-26T17:06:52.797142\",\n\t\t\"state\": \"active\",\n\t\t\"id\": \"73b27243-0c1e-4883-8a01-1492cf2b333c\"\n\t},\n\t{\n\t\t\"vocabulary_id\":
  null,\n\t\t\"display_name\": \"infection\",\n\t\t\"name\": \"infection\",\n\t\t\"revision_timestamp\":
  \"2015-02-26T17:06:52.797142\",\n\t\t\"state\": \"active\",\n\t\t\"id\": \"4b20ad8a-599d-4694-bc07-d512dd1a6612\"\n\t},\n\t{\n\t\t\"vocabulary_id\":
  null,\n\t\t\"display_name\": \"medication\",\n\t\t\"name\": \"medication\",\n\t\t\"revision_timestamp\":
  \"2015-02-26T17:06:52.797142\",\n\t\t\"state\": \"active\",\n\t\t\"id\": \"55abcf62-0aa3-4553-b5a8-5db5d36c443e\"\n\t},\n\t{\n\t\t\"vocabulary_id\":
  null,\n\t\t\"display_name\": \"neutrophils\",\n\t\t\"name\": \"neutrophils\",\n\t\t\"revision_timestamp\":
  \"2015-02-26T17:06:52.797142\",\n\t\t\"state\": \"active\",\n\t\t\"id\": \"8287ae1d-41e8-40de-b902-c0db4e40e9df\"\n\t},\n\t{\n\t\t\"vocabulary_id\":
  null,\n\t\t\"display_name\": \"patient\",\n\t\t\"name\": \"patient\",\n\t\t\"revision_timestamp\":
  \"2015-02-26T17:06:52.797142\",\n\t\t\"state\": \"active\",\n\t\t\"id\": \"84651278-c505-44da-a3b6-6115676c70ff\"\n\t},\n\t{\n\t\t\"vocabulary_id\":
  null,\n\t\t\"display_name\": \"registry\",\n\t\t\"name\": \"registry\",\n\t\t\"revision_timestamp\":
  \"2015-02-26T17:06:52.797142\",\n\t\t\"state\": \"active\",\n\t\t\"id\": \"227efa14-9230-4507-badf-3e410603c3db\"\n\t},\n\t{\n\t\t\"vocabulary_id\":
  null,\n\t\t\"display_name\": \"va\",\n\t\t\"name\": \"va\",\n\t\t\"revision_timestamp\":
  \"2015-02-26T17:06:52.797142\",\n\t\t\"state\": \"active\",\n\t\t\"id\": \"5c740e0c-4cbe-421a-a4d4-b0c59ba3986b\"\n\t},\n\t{\n\t\t\"vocabulary_id\":
  null,\n\t\t\"display_name\": \"veteran\",\n\t\t\"name\": \"veteran\",\n\t\t\"revision_timestamp\":
  \"2015-02-26T17:06:52.797142\",\n\t\t\"state\": \"active\",\n\t\t\"id\": \"7561bea1-6f6c-4e42-96cc-7a5271ea4f8c\"\n\t}],\n\t\"title\":
  \"VA National Clozapine Registry\",\n\t\"tracking_summary\": {\n\t\t\"total\": 665,\n\t\t\"recent\":
  19\n\t},\n\t\"groups\": [],\n\t\"relationships_as_subject\": [],\n\t\"revision_timestamp\":
  \"2015-08-21T22:53:33.174925\",\n\t\"name\": \"va-national-clozapine-registry\",\n\t\"isopen\":
  true,\n\t\"url\": null,\n\t\"notes\": \"The VA National Clozapine Registry tracks
  the health and demographics of patients who have been prescribed clozapine by the
  VA. Clozapine, or the brand name Clozaril, is a drug used to treat the most serious
  cases of schizophrenia. Unfortunately, clozapine may also affect portions of the
  blood, lowering the body's resistance to infection and sometimes creating life-threatening
  circumstances. Realizing the severity of the problem, the Food and Drug Administration
  (FDA) established guidelines for analysis of White Blood Cells and Neutrophils and
  set strict minimum limits. The FDA also mandated that any manufacturer of clozapine
  must maintain a Clozapine Registry. These registries are to track the location and
  the health of clozapine patients and to ensure 'weekly White Blood Cell testing
  prior to delivery of the next week's supply of medication'. To date, the clozapine
  manufacturer registries have been unable to develop sufficient controls to meet
  these requirements, especially the ability to prevent dispensing clozapine when
  blood results are abnormal. However, because of the unique structure of Veterans
  Health Information Systems and Technology Architecture, the Veterans Health Administration
  obtained permission from the FDA and clozapine manufacturers to use its in-place
  computer network to gather and evaluate weekly patient information, then export
  this data to manufacturer clozapine registries. The VA assigned functional administration
  of this effort to the National Clozapine Coordinating Center (NCCC) located in Dallas,
  Texas. Weekly data on each VA clozapine patient is processed at two locations. Facility
  Level --When a clozapine prescription is written, a computer program in each facility's
  internal computer system retrieves white blood cell count, neutrophil count, and
  clozapine dose and evaluates the information according to FDA guidelines. If an
  adverse blood condition is found, the computer may warn to trigger a physician reevaluation,
  or lock out entirely to prevent dispensing, depending on the severity. Weekly, this
  information, along with certain patient demographic information, is gathered locally
  and transmitted to Hines Office of Information & Technology Field Office for centralized
  storage. This data can only be accessed by the NCCC. Raw data is downloaded from
  the Hines OI Field Office database on a weekly basis. An ancillary computer program
  reformats the data and evaluates the information for inconsistencies and data gathering
  errors. The computer-corrected data is manually compared with hand-written facsimile
  information sent to the NCCC by each site. This manually corrected data is again
  reformatted for data storage in MS Access format at the NCCC. The corrected data
  is also reformatted into American Standard Code for Information Interchange fixed-length
  fields and transmitted via modem to the manufacturers' Clozapine Registry and, in
  turn, to the FDA.\",\n\t\"license_title\": \"Creative Commons CCZero\",\n\t\"extras\":
  [{\n\t\t\"key\": \"harvest_source_id\",\n\t\t\"value\": \"e868f753-9395-4666-a30c-219334a64c6b\"\n\t},\n\t{\n\t\t\"key\":
  \"resource-type\",\n\t\t\"value\": \"Dataset\"\n\t},\n\t{\n\t\t\"key\": \"modified\",\n\t\t\"value\":
  \"2013-12-30\"\n\t},\n\t{\n\t\t\"key\": \"source_hash\",\n\t\t\"value\": \"8a68af09fb65f34fa826d053f9d7adf438063b57\"\n\t},\n\t{\n\t\t\"key\":
  \"temporal\",\n\t\t\"value\": \"1991-01-01/2014-12-31\"\n\t},\n\t{\n\t\t\"key\":
  \"spatial\",\n\t\t\"value\": \"United States\"\n\t},\n\t{\n\t\t\"key\": \"catalog_conformsTo\",\n\t\t\"value\":
  \"https://project-open-data.cio.gov/v1.1/schema\"\n\t},\n\t{\n\t\t\"key\": \"catalog_@context\",\n\t\t\"value\":
  \"https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld\"\n\t},\n\t{\n\t\t\"key\":
  \"catalog_describedBy\",\n\t\t\"value\": \"https://project-open-data.cio.gov/v1.1/schema/catalog.json\"\n\t},\n\t{\n\t\t\"key\":
  \"harvest_source_title\",\n\t\t\"value\": \"VA JSON\"\n\t},\n\t{\n\t\t\"key\": \"source_schema_version\",\n\t\t\"value\":
  \"1.1\"\n\t},\n\t{\n\t\t\"key\": \"programCode\",\n\t\t\"value\": [\"029:041\"]\n\t},\n\t{\n\t\t\"key\":
  \"bureauCode\",\n\t\t\"value\": [\"029:15\"]\n\t},\n\t{\n\t\t\"key\": \"accessLevel\",\n\t\t\"value\":
  \"non-public\"\n\t},\n\t{\n\t\t\"key\": \"harvest_object_id\",\n\t\t\"value\": \"b64b4c13-ceec-4fc0-9208-c56e838985d4\"\n\t},\n\t{\n\t\t\"key\":
  \"publisher\",\n\t\t\"value\": \"Department of Veterans Affairs\"\n\t},\n\t{\n\t\t\"key\":
  \"language\",\n\t\t\"value\": [\"en-US\"]\n\t},\n\t{\n\t\t\"key\": \"license\",\n\t\t\"value\":
  \"https://creativecommons.org/publicdomain/zero/1.0/\"\n\t},\n\t{\n\t\t\"key\":
  \"rights\",\n\t\t\"value\": \"Health Insurance Portability and Accountability Act,
  protected health information.\"\n\t},\n\t{\n\t\t\"key\": \"systemOfRecords\",\n\t\t\"value\":
  \"http://www.gpo.gov/fdsys/pkg/FR-2012-05-11/pdf/2012-11487.pdf\"\n\t},\n\t{\n\t\t\"key\":
  \"source_datajson_identifier\",\n\t\t\"value\": true\n\t},\n\t{\n\t\t\"key\": \"dataQuality\",\n\t\t\"value\":
  true\n\t},\n\t{\n\t\t\"key\": \"identifier\",\n\t\t\"value\": \"VA-VHA-PBM-005\"\n\t},\n\t{\n\t\t\"state\":
  \"active\",\n\t\t\"key\": \"harvest_object_id\",\n\t\t\"value\": \"b64b4c13-ceec-4fc0-9208-c56e838985d4\"\n\t},\n\t{\n\t\t\"state\":
  \"active\",\n\t\t\"key\": \"harvest_source_id\",\n\t\t\"value\": \"e868f753-9395-4666-a30c-219334a64c6b\"\n\t},\n\t{\n\t\t\"state\":
  \"active\",\n\t\t\"key\": \"harvest_source_title\",\n\t\t\"value\": \"VA JSON\"\n\t}],\n\t\"license_url\":
  \"http://www.opendefinition.org/licenses/cc-zero\",\n\t\"organization\": {\n\t\t\"description\":
  \"\",\n\t\t\"created\": \"2013-05-18T11:31:11.529883\",\n\t\t\"title\": \"Department
  of Veterans Affairs\",\n\t\t\"name\": \"va-gov\",\n\t\t\"revision_timestamp\": \"2014-11-19T19:55:14.636069\",\n\t\t\"is_organization\":
  true,\n\t\t\"state\": \"active\",\n\t\t\"image_url\": \"https://raw.githubusercontent.com/GSA/logo/master/va.png\",\n\t\t\"revision_id\":
  \"7c651ccc-eb67-439e-82dd-1ae7fff33f63\",\n\t\t\"type\": \"organization\",\n\t\t\"id\":
  \"ff9ae098-eccc-41d8-bfcd-5e8ed047db05\",\n\t\t\"approval_status\": \"approved\"\n\t},\n\t\"revision_id\":
  \"1e2c6af7-5b4b-40f9-adaa-ba91e8be9c29\"\n}"